awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q27675380-12669E13-ADFD-4CF1-AB41-C388B9044A1B
Q27675380-12669E13-ADFD-4CF1-AB41-C388B9044A1B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27675380-12669E13-ADFD-4CF1-AB41-C388B9044A1B
A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants
P2860
Q27675380-12669E13-ADFD-4CF1-AB41-C388B9044A1B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27675380-12669E13-ADFD-4CF1-AB41-C388B9044A1B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
067d431670fecd3adc35c6b5fda0dc2c47e6c8bd
P2860
Efficacy and safety of rilpivirine (TMC278) versus efavirenz at 48 weeks in treatment-naive HIV-1-infected patients: pooled results from the phase 3 double-blind randomized ECHO and THRIVE Trials.